Performance analysis of Oncternal Therapeutics (ONCT)
Annual Return
Over the past 3 years, ONCT has had an average annual return of -52.67%, underperforming the benchmark SPY, which returned +22.45% annual.
Over the past 5 years, ONCT has had an average annual return of -69.19%, underperforming the benchmark SPY, which returned +13.88% annual.
Over the past 10 years, ONCT has had an average annual return of -52.04%, underperforming the benchmark SPY, which returned +15.45% annual.
Since Feb 3, 2004, ONCT has had an average annual return of -35.75%, underperforming the benchmark SPY, which returned +10.85% annual.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -83.33% | -45.45% | -56.00% | -53.70% | +22.73% | -26.67% | -93.91% | +140.83% | -24.68% | -4.06% | -55.75% | -60.72% |
| 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
| +24.99% | +26.83% | -36.92% | -75.06% | +17.35% | -19.56% | +135.99% | -43.96% | +4.57% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -16.67% | +0% | +0% | +0% | +0% | -20.00% | +0% | -50.00% | -50.00% | +0% | +0% | -83.33% | |
| 2023 | +9.09% | -16.67% | -10.00% | -66.67% | +0% | +33.33% | +0% | -25.00% | +0% | +33.33% | +0% | +50% | -45.45% |
| 2022 | -16.00% | -4.76% | -25.00% | -40.00% | +77.78% | -25.00% | -8.33% | +9.09% | -16.67% | +20% | -16.67% | +10% | -56.00% |
| 2021 | +11.11% | +20% | +27.78% | -23.91% | -10.00% | -15.87% | -18.87% | +16.28% | -8.00% | -10.87% | -19.51% | -24.24% | -53.70% |
| 2020 | -4.55% | -4.76% | -20.00% | -9.38% | +17.24% | -8.82% | +3.23% | -25.00% | -20.83% | -10.53% | +82.35% | +74.19% | +22.73% |
| 2019 | +40% | -7.14% | +19.23% | -9.68% | +8.33% | -18.68% | -32.43% | +24% | -11.29% | +7.27% | +5.08% | -29.03% | -26.67% |
| 2018 | +19.80% | +5.17% | +10.88% | -4.22% | +18.82% | -24.20% | +6.57% | +46.56% | -93.42% | +0.82% | -8.94% | -46.43% | -93.91% |
| 2017 | +6.60% | -16.28% | +4.11% | -12.37% | -28.53% | +72.27% | +4.88% | +18.84% | +27.98% | -3.21% | +60.51% | -3.05% | +140.83% |
Drawdown analysis of Oncternal Therapeutics (ONCT)
The maximum drawdown for the ONCT was -99.99%, occurring on Sep 12, 2024. This drawdown has not yet recovered.
The current ONCT drawdown is -99.99%.
Since Feb 3, 2004 ONCT has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 2 times
- 30% or more: 3 times
- 20% or more: 4 times
- 10% or more: 6 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.99% | Apr 25, 2007 | 4376 | Sep 12, 2024 | Ongoing | Ongoing | Ongoing |
| -49.98% | Nov 23, 2004 | 256 | Nov 29, 2005 | 253 | Nov 30, 2006 | 509 |
| -39.81% | May 3, 2004 | 55 | Jul 22, 2004 | 87 | Nov 23, 2004 | 142 |
| -25.04% | Feb 3, 2004 | 38 | Mar 29, 2004 | 18 | Apr 23, 2004 | 56 |
| -13.82% | Mar 12, 2007 | 11 | Mar 27, 2007 | 14 | Apr 17, 2007 | 25 |
| -13.50% | Dec 28, 2006 | 6 | Jan 9, 2007 | 15 | Jan 31, 2007 | 21 |
| -5.70% | Dec 15, 2006 | 1 | Dec 18, 2006 | 3 | Dec 21, 2006 | 4 |
| -5.34% | Feb 26, 2007 | 4 | Mar 2, 2007 | 6 | Mar 12, 2007 | 10 |
| -5.12% | Apr 17, 2007 | 2 | Apr 19, 2007 | 3 | Apr 24, 2007 | 5 |
| -4.53% | Feb 2, 2007 | 2 | Feb 6, 2007 | 10 | Feb 21, 2007 | 12 |
| -2.80% | Apr 28, 2004 | 2 | Apr 30, 2004 | 1 | May 3, 2004 | 3 |
| -1.59% | Dec 8, 2006 | 3 | Dec 13, 2006 | 1 | Dec 14, 2006 | 4 |
| -1.25% | Dec 21, 2006 | 2 | Dec 26, 2006 | 2 | Dec 28, 2006 | 4 |
| -0.75% | Apr 26, 2004 | 1 | Apr 27, 2004 | 1 | Apr 28, 2004 | 2 |
| -0.54% | Dec 4, 2006 | 1 | Dec 5, 2006 | 1 | Dec 6, 2006 | 2 |